UNDERSTANDING AND OVERCOMING PARENTAL VACCINE HESITANCY by Alexandru Paul Baciu, Ancuta Lupu, Ginel Baciu, Carmen Baciu, Tatiana Chisnoiu, Lorenza Forna, Vlad Andrei Pitea, Adriana Luminita Balasa, Larisia Mihai, Bianca-Maria Constantin, Ramona Mihaela Stoicescu, Vasile Valeriu Lupu, Cristina Maria Mihai

Subjects: “…vaccination; parents; trust; adverse effects; immunization; attitudes…”
Get full text

Surveillance of Adverse Events Following Varicella Vaccine Immunization in Zhejiang Province, China, from 2020 to 2022 by Hui Liang, Xiaohua Qi, Yaping Chen, Xuejiao Pan

Subjects: Get full text

Analysis of ADR reports of cetuximab based on the FDA adverse event reporting system database by Shuai Zhao, Yan Wang, Xiaoli Deng, Xi Chen, Zhaoyi Lu

Subjects: Get full text

The Recognition and Management of Adverse Effects in Electroconvulsive Therapy: Findings From a Finnish Survey Study by Saara H. Huoponen, Katrin Sisa, Tom Saari, Markku Taittonen, Ulla Ahlmén‐Laiho

Subjects: “…adverse effects…”
Get full text

Impact of discontinuation of cephazolin prophylaxis on the incidence of postoperative adverse events in cataract surgery by Kazutaka Uchida, Keita Takahama, Kenshiro Higashi, Yuki Kusano, Koki Matsumoto, Yoshihiro Nakagawa, Kazutaka Oda

Subjects: Get full text

Characteristics of and treatment outcomes in rifampicin-intolerant patients by R. Mangat, S.K. Brode, H.K. Mah, M.S. Brar, N.F. Sabur

Subjects: Get full text

Auricular Acupuncture for Perioperative Pain Management: A Systematic Review and Meta-Analysis of Randomized Controlled Trials by Zhou Y, Bao Q, Yang C, Li S, Yin Z, Xiong J, Sun M, Yang J, Liu F, Liang F

Subjects: Get full text

Associated adverse outcomes with tumor treating fields when combined to temozolomide versus temozolomide alone for the treatment of glioblastoma: a meta-analysis of randomized tria... by Yuanyuan Chen, Yan Chen, Hong Zhen, Danhua Lou

Subjects: “…Adverse outcomes…”
Get full text

Dermatologic Adverse Events Following Afatinib in a Woman with Non-Small-Cell Lung Cancer: A Case Report by Tsaqilah L, Putri AD, Avriyanti E

Subjects: Get full text

Prevalence, risk factors, and adverse outcomes of bacterial vaginosis among pregnant women: a systematic review by Neha Sethi, Vallikkannu Narayanan, Rahmah Saaid, Aizura Syafinaz Ahmad Adlan, Soo Tein Ngoi, Cindy Shuan Ju Teh, Mashitah Hamidi, on behalf of WHOW research group

Subjects: Get full text

Risk factors for severe adverse drug reactions in hospitalized patients by Petrović Nemanja Z., Pejčić Ana V., Milosavljević Miloš N., Janković Slobodan M.

Subjects: “…severe adverse drug reactions…”
Get full text

Timeline of cognitive impairments after radiotherapy for head and neck cancer: A review by K. Wickborn, C.W.J. van der Weijden, E.F.J. de Vries, T.W.H. Meijer, M.C.A. Kramer, J.M. Spikman, A.M. Buunk, A. van der Hoorn

Subjects: Get full text

Lamotrigine-Related Skin Rash by J. Jokubaitė, L. Martinėlė, G. Joskaudaitė, T. Raudonis

Subjects: Get full text

Adverse childhood experiences screening in pediatric primary care and changes in the rate of visits to social work and behavioral health by Sonya Negriff, Margo Sidell, Lee Barton, Mercie J. DiGangi

Subjects: “…Adverse childhood experiences…”
Get full text

Brodalumab: Six-Year US Pharmacovigilance Report by Mark G. Lebwohl, John Y. Koo, April W. Armstrong, Bruce E. Strober, Soo Han Yoon, Nicole N. Rawnsley, Earl L. Goehring, Gina D. Mangin, Abby A. Jacobson

Subjects: “…Adverse events…”
Get full text

Trends and factors associated with adverse pregnancy outcomes in Zimbabwe, 2005 - 2015 by T Chibura, H Twabi, K Maluleke, A Musekiwa

Subjects: Get full text

Barriers to and facilitators of healthcare professionals in ADR reporting in a tertiary care hospital in India by Ian Osoro N, Suhaib KP, Jamuna Rani R, Rajanandh MG

Subjects: “…Adverse drug reaction…”
Get full text

A meta-analysis of risk factors for cardiovascular adverse events with anthracycline based chemotherapy in lymphoma patients by Bo Dai, Jingjing Xu, Baiyan Wang

Subjects: Get full text

Mucocutaneous Adverse Events in Patients With Cancer Treated with the Highly Selective RET Kinase Inhibitor Selpercatinib (LOXO-292) by Rachel E. Reingold, MD, Rose Parisi, MD, MBA, Guilherme Harada, MD, Andrea P. Moy, MD, George Dranitsaris, PhD, Jasmine H. Francis, MD, Julia Canestraro, OD, FAAO, Julia A. Lester, MPH, Lauren A. Kaplanis, RN, Dazhi Liu, PharmD, BCOP, Mario E. Lacouture, MD, Alexander Drilon, MD

Subjects: Get full text